Form 144 BRIDGEBIO PHARMA For: 10 March

Risk disclosure: Trading financial instruments and cryptocurrencies carries high risk, including the potential loss of some or all invested capital, and crypto prices are described as extremely volatile and sensitive to financial, regulatory or political events. Trading on margin amplifies those risks and investors are advised to consider objectives, experience and seek professional advice. Fusion Media warns its website data may not be real-time or accurate, that prices may be indicative rather than tradeable, and disclaims liability for trading losses.

Analysis

A surge in scrutiny around data provenance and venue transparency is a structural positive for regulated, auditable infrastructure providers and a direct negative for lightly regulated retail venues and opaque data vendors. Expect a reallocation of trading flow: conservatively, 3–7% of current retail crypto notional could migrate to regulated on‑/off‑ramps and cleared derivatives over 6–18 months as counterparties price in litigation and reputational risk. This reallocative force compounds volatility because liquidity will concentrate into fewer venues while margin requirements rise, expanding realized and implied vols in event windows by 20–40% versus baseline.

Second‑order winners include exchanges and clearinghouses that can credibly guarantee price integrity (CME/ICE/LSEG) and oracle/custody providers that offer cryptographic proofs and attested feeds (on‑chain or hybrid). Losers are regional unregulated platforms, boutique market makers that relied on proprietary non‑auditable feeds, and advertisers/aggregators whose business models assume benign price dispersion — expect elevated compliance costs and client redemptions. A practical knock‑on is higher initial margin and liquidity premia for OTC desks, pressuring levered retail and prop funds first.

Key catalysts: (1) a headline mispricing/litigation event or regulator enforcement within 0–3 months that forces immediate flow repricing; (2) published standards or legislation in 6–24 months that formalizes data/audit requirements and accelerates market share shifts. Tail risks include an oracle compromise or concerted on‑chain attack that triggers systemic liquidations within days, which would temporarily invert the winner/loser map. Monitor on‑chain oracle uptime, exchange trade surveillance filings, and large client migration announcements as high‑information indicators.

Key Decisions for Investors

• Long CME Group (CME) 12‑18 month call spread (buy 2027 Jan 1x call, sell 2027 Jan higher strike) sized to 1–2% NAV: asymmetric payoff from sustained flow migration to cleared, regulated derivatives; hedge by selling into 20–30% single‑day rallies.
• Buy Chainlink (LINK) spot or 6–12 month call exposure (~0.75–1% NAV): secular demand for decentralized/verifiable price oracles should reprice LINK higher if institutional on‑chain settlement grows; set 30% trailing stop, target 2.5x downside/upside within 12 months.
• Pair trade: long LSEG (LSEG) 9–12 month calls / short Robinhood (HOOD) 9–12 month calls (equal notional, 1–1.5% NAV): captures flow shift from retail‑centric, brand‑sensitive venues to regulated data/clearing providers; unwind if HOOD user retention metrics stabilize for two consecutive quarters.
• Volatility tactical: buy 1‑month BTC and ETH straddles around any major data‑integrity/regulatory announcement (allocate small, e.g., 0.5–1% NAV each): protects against jump risk and monetizes short‑term uncertainty spikes; close within 3–7 trading days or on realized IV doubling.